(Q49161329)

18 February 2018

title

Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. (English)

1 reference

18 February 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

Berger R

1

1 reference

18 February 2018

Huelsmann M

2

1 reference

18 February 2018

Strecker K

3

1 reference

18 February 2018

Moertl D

4

1 reference

18 February 2018

Moser P

5

1 reference

18 February 2018

Bojic A

6

1 reference

18 February 2018

Pacher R

7

1 reference

18 February 2018

publication date

1 January 2005

1 reference

18 February 2018

European Journal of Clinical Investigation

published in

1 reference

18 February 2018

volume

35

1 reference

18 February 2018

issue

1

1 reference

18 February 2018

page(s)

24-31

1 reference

18 February 2018

The impending crisis awaiting cardiac transplantation. Modeling a solution based on selection

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

Long-term use of a left ventricular assist device for end-stage heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

Biochemical detection of left-ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

Risk stratification in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01442.X

10.1111/J.1365-2362.2005.01442.X

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018